U.S. Small Molecule Innovator API CDMO Market 2030: Preclinical...

added blog Other

2025-06-30 11:19:43 -

U.S. Small Molecule Innovator API CDMO Market 2030: Preclinical Growth Trends

In 2024, the U.S. market for small molecule innovator API CDMOs was valued at USD 8.80 billion, with projections indicating it will expand at a compound annual growth rate (CAGR) of 6.0% from 2025 to 2030. Key drivers fueling this growth include increasing outsourcing by pharmaceutical firms, sustained demand for small-molecule drugs, and the growing number of clinical trials...

0 Comments 0 Shares 83 Views 0 Reviews